Pharma majors Dr Reddy’s Laboratories and Aurobindo Pharma have recalled some doses of two separate products from the US market. The recalled drugs were Olanzapine tablets and Pantoprazole Sodium for injection respectively, according to a notification of the US Food and Drug Administration (USFDA). Both the recalls are voluntarily initiated by respective companies, the FDA said. The recalls come under Class-III classification of USFDA which was described as "a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.’’

Olanzapine tablets are indicated for treating schizophrenia or bipolar disorder and Pantoprazole sodium for injection is indicated for short-term treatment of adult patients with gastroesophageal reflux disease.